{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:29:18Z","timestamp":1767983358800,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Numerous studies have investigated the association between eosinophilia and clinical outcome of patients with chronic obstructive pulmonary disease (COPD) but the evidence is conflicting. We conducted a pooled analysis of outcome measures comparing eosinophilic and non-eosinophilic COPD patients. We searched articles indexed in four databases using Medical Subject Heading or Title and Abstract words including COAD, COPD, eosinophil, eosinophilia, eosinopenia from inception to December 2016. Observational studies and randomized controlled trials with parallel groups comparing COPD patients with and without eosinophilia were included. Comparing to the non-eosinophilic group, those with eosinophilic COPD had a similar risk for exacerbation in 12 months [Odds ratio\u2009=\u20091.07, 95% confidence interval (CI) 0.86\u20131.32, <jats:italic>P<\/jats:italic>\u2009=\u20090.55] and in-hospital mortality [OR\u2009=\u20090.52, 95% CI 0.25\u20131.07]. Eosinophilia was associated with reduced length of hospital stay (<jats:italic>P<\/jats:italic>\u2009=\u20090.04). Subsequent to therapeutic interventions, eosinophilic outpatients performed better in pulmonary function tests [Mean Difference\u2009=\u20091.64, 95% CI 0.05\u20133.23, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001]. Inclusion of hospitalized patients nullified the effect. Improvement of quality of life was observed in eosinophilic subjects [Standardized Mean Difference\u2009=\u20091.83, 95% CI 0.02\u20133.64, <jats:italic>P<\/jats:italic>\u2009=\u20090.05], independent of hospitalization status. In conclusion, blood eosinophilia may be predictive of favorable response to steroidal and bronchodilator therapies in patients with stable COPD.<\/jats:p>","DOI":"10.1038\/s41598-017-13745-x","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T10:27:49Z","timestamp":1507804069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis"],"prefix":"10.1038","volume":"7","author":[{"given":"Jeffery","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T. V.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5510-1253","authenticated-orcid":false,"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-9310","authenticated-orcid":false,"given":"Sunny H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Czarina C. H.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose Y. P","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Gin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson W. M.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K. K.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley P. C.","family":"Ngai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"13745_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1183\/09031936.02.00286302","volume":"20","author":"RE Louis","year":"2002","unstructured":"Louis, R. E. et al. Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease. Eur Respir J. \n                           20, 325\u2013331 (2002).","journal-title":"Eur Respir J."},{"issue":"Suppl 6","key":"13745_CR2","first-page":"261","volume":"59","author":"K Gorska","year":"2008","unstructured":"Gorska, K. et al. Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma. J Physiol Pharmacol. \n                           59(Suppl 6), 261\u2013270 (2008).","journal-title":"J Physiol Pharmacol."},{"key":"13745_CR3","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1164\/ajrccm.160.5.9810105","volume":"160","author":"G Balzano","year":"1999","unstructured":"Balzano, G. et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med. \n                           160, 1486\u20131492 (1999).","journal-title":"Am J Respir Crit Care Med."},{"key":"13745_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/COPD.S4854","volume":"4","author":"E Bathoorn","year":"2009","unstructured":"Bathoorn, E. et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J Chron Obstruct Pulmon Dis. \n                           4, 101\u2013109 (2009).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"13745_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2147\/COPD.S100338","volume":"11","author":"NA Negewo","year":"2016","unstructured":"Negewo, N. A. et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. \n                           11, 1495\u20131504 (2016).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"13745_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1183\/09031936.05.00047504","volume":"25","author":"K Fujimoto","year":"2005","unstructured":"Fujimoto, K. et al. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J. \n                           25, 640\u2013646 (2005).","journal-title":"Eur Respir J."},{"key":"13745_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","volume":"193","author":"S Vedel-Krogh","year":"2016","unstructured":"Vedel-Krogh, S., Nielsen, S. F., Lange, P., Vestbo, J. & Nordestgaard, B. G. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen general population study. Am J Respir Crit Care Med. \n                           193, 965\u2013974 (2016).","journal-title":"Am J Respir Crit Care Med."},{"key":"13745_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/resp.12475","volume":"20","author":"O Eltboli","year":"2015","unstructured":"Eltboli, O., Mistry, V., Barker, B. & Brightling, C. E. Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease. Respirology. \n                           20, 667\u2013670 (2015).","journal-title":"Respirology."},{"key":"13745_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/thx.2004.032516","volume":"60","author":"CE Brightling","year":"2005","unstructured":"Brightling, C. E. et al. Sputum eosinophilia and the short-term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. \n                           60, 193\u2013198 (2005).","journal-title":"Thorax."},{"key":"13745_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","volume":"186","author":"M Bafadhel","year":"2012","unstructured":"Bafadhel, M. et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. \n                           186, 48\u201355 (2012).","journal-title":"Am J Respir Crit Care Med."},{"key":"13745_CR11","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1183\/13993003.01370-2015","volume":"47","author":"NC Barnes","year":"2016","unstructured":"Barnes, N. C., Sharma, R., Lettis, S. & Calverley, P. M. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD. Eur Respir J. \n                           47, 1374\u20131382 (2016).","journal-title":"Eur Respir J."},{"key":"13745_CR12","first-page":"10","volume":"10","author":"MH Rahimi-Rad","year":"2015","unstructured":"Rahimi-Rad, M. H., Asgari, B., Hosseinzadeh, N. & Eishi, A. Eosinopenia as a marker of outcome in acute exacerbations of chronic obstructive pulmonary disease. Maedica (Buchar). \n                           10, 10\u201313 (2015).","journal-title":"Maedica (Buchar)."},{"key":"13745_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","volume":"71","author":"ID Pavord","year":"2016","unstructured":"Pavord, I. D. et al. Blood eosinophils and inhaled corticosteroid\/ long-acting beta-2 agonist efficacy in COPD. Thorax. \n                           71, 118\u2013125 (2016).","journal-title":"Thorax."},{"key":"13745_CR14","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.2147\/COPD.S88058","volume":"10","author":"C Salturk","year":"2015","unstructured":"Salturk, C. et al. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit? Int J Chron Obstruct Pulmon Dis. \n                           10, 1837\u20131846 (2015).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"13745_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pupt.2016.03.004","volume":"37","author":"L Serafino-Agrusa","year":"2016","unstructured":"Serafino-Agrusa, L., Scichilone, N., Spatafora, M. & Battaglia, S. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: a case-control study. Pulm Pharmacol Ther. \n                           37, 89\u201394 (2016).","journal-title":"Pulm Pharmacol Ther."},{"key":"13745_CR16","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.2147\/COPD.S90330","volume":"10","author":"D Duman","year":"2015","unstructured":"Duman, D. et al. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Int J Chron Obstruct Pulmon Dis. \n                           10, 2469\u20132478 (2015).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"13745_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1440-1843.2009.01651.x","volume":"15","author":"M Holland","year":"2010","unstructured":"Holland, M., Alkhalil, M., Chandromouli, S., Janjua, A. & Babores, M. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology. \n                           15, 165\u2013167 (2010).","journal-title":"Respirology."},{"key":"13745_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.chest.2016.01.026","volume":"150","author":"M Bafadhel","year":"2016","unstructured":"Bafadhel, M. et al. Blood eosinophils and outcomes in severe hospitalised exacerbations of COPD. Chest. \n                           150, 320\u2013328 (2016).","journal-title":"Chest."},{"key":"13745_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","volume":"151","author":"S Couillard","year":"2017","unstructured":"Couillard, S., Larivee, P., Courteau, J. & Vanasse, A. Eosinophils in chronic obstructive pulmonary disease exacerbations are associated with increased readmissions. Chest. \n                           151, 366\u2013373 (2017).","journal-title":"Chest."},{"key":"13745_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010099","volume":"6","author":"DR Hinds","year":"2016","unstructured":"Hinds, D. R., DiSantostefano, R. L., Le, H. V. & Pascoe, S. Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis. BMJ Open. \n                           6, e010099 (2016).","journal-title":"BMJ Open."},{"key":"13745_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1164\/rccm.200203-183OC","volume":"167","author":"LM Fabbri","year":"2003","unstructured":"Fabbri, L. M. et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. \n                           167, 418\u2013424 (2003).","journal-title":"Am J Respir Crit Care Med."},{"key":"13745_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel, M. et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. \n                           184, 662\u2013671 (2011).","journal-title":"Am J Respir Crit Care Med."},{"key":"13745_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-151","volume":"6","author":"PF Mercer","year":"2005","unstructured":"Mercer, P. F. et al. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res. \n                           6, 151 (2005).","journal-title":"Respir Res."},{"key":"13745_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1183\/09031936.00146306","volume":"29","author":"R Siva","year":"2007","unstructured":"Siva, R. et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J. \n                           29, 906\u2013913 (2007).","journal-title":"Eur Respir J."},{"key":"13745_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000221902","volume":"78","author":"M Bafadhel","year":"2009","unstructured":"Bafadhel, M. et al. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD. Respiration. \n                           78, 256\u2013262 (2009).","journal-title":"Respiration."},{"key":"13745_CR26","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","volume":"356","author":"CE Brightling","year":"2000","unstructured":"Brightling, C. E. et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. \n                           356, 1480\u20131485 (2000).","journal-title":"Lancet."},{"key":"13745_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40261-015-0322-6","volume":"35","author":"A Iqbal","year":"2015","unstructured":"Iqbal, A., Barnes, N. C. & Brooks, J. Is Blood eosinophil count a predictor of response to bronchodilators in chronic obstructive pulmonary disease? results from post-hoc subgroup analyses. Clin Drug Investig. \n                           35, 685\u2013688 (2015).","journal-title":"Clin Drug Investig."},{"key":"13745_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1183\/09031936.98.12020380","volume":"12","author":"A Pesci","year":"1998","unstructured":"Pesci, A. et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J. \n                           12, 380\u2013386 (1998).","journal-title":"Eur Respir J."},{"key":"13745_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1183\/09031936.00137006","volume":"31","author":"JB Snoeck-Stroband","year":"2008","unstructured":"Snoeck-Stroband, J. B. et al. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J. \n                           31, 70\u201377 (2008).","journal-title":"Eur Respir J."},{"key":"13745_CR30","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","volume":"173","author":"A Papi","year":"2006","unstructured":"Papi, A. et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. \n                           173, 1114\u20131121 (2006).","journal-title":"Am J Respir Crit Care Med."},{"key":"13745_CR31","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2147\/COPD.S80992","volume":"10","author":"A Zanini","year":"2015","unstructured":"Zanini, A. et al. Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. \n                           10, 1155\u20131161 (2015).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"13745_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00408-005-2586-8","volume":"184","author":"DW Perng","year":"2006","unstructured":"Perng, D. W. et al. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility. Lung. \n                           184, 217\u2013222 (2006).","journal-title":"Lung."},{"key":"13745_CR33","first-page":"283","volume":"7","author":"Y Kitaguchi","year":"2012","unstructured":"Kitaguchi, Y., Komatsu, Y., Fujimoto, K., Hanaoka, M. & Kubo, K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis. \n                           7, 283\u2013289 (2012).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"13745_CR34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1378\/chest.115.3.697","volume":"115","author":"K Fujimoto","year":"1999","unstructured":"Fujimoto, K., Kubo, K., Yamamoto, H., Yamaguchi, S. & Matsuzawa, Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest. \n                           115, 697\u2013702 (1999).","journal-title":"Chest."},{"key":"13745_CR35","first-page":"23","volume":"11","author":"HY Park","year":"2016","unstructured":"Park, H. Y. et al. Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting \u03b22-agonist treatment in stable COPD patients. Int J Chron Obstruct Pulmon Dis. \n                           11, 23\u201330 (2016).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"13745_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-14-112","volume":"14","author":"O Eltboli","year":"2014","unstructured":"Eltboli, O. et al. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils. BMC Pulm Med. \n                           14, 112 (2014).","journal-title":"BMC Pulm Med."},{"key":"13745_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-10-113","volume":"10","author":"JM D\u2019Armiento","year":"2009","unstructured":"D\u2019Armiento, J. M. et al. Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res. \n                           10, 113 (2009).","journal-title":"Respir Res."},{"key":"13745_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.rmed.2016.01.013","volume":"112","author":"RL DiSantostefano","year":"2016","unstructured":"DiSantostefano, R. L., Hinds, D., Le, H. V. & Barnes, N. C. Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort. Respir Med. \n                           112, 88\u201396 (2016).","journal-title":"Respir Med."},{"key":"13745_CR39","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1183\/09031936.00162414","volume":"44","author":"D Singh","year":"2014","unstructured":"Singh, D. et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. \n                           44, 1697\u20131700 (2014).","journal-title":"Eur Respir J."},{"key":"13745_CR40","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1378\/chest.130.4.1157","volume":"130","author":"H van der Vaart","year":"2006","unstructured":"van der Vaart, H. et al. Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. Chest. \n                           130, 1157\u20131164 (2006).","journal-title":"Chest."},{"key":"13745_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher, D. et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. Ann Intern Med \n                           151, 264\u2013269 (2009).","journal-title":"Ann Intern Med"},{"key":"13745_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins, J. P. et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomized trials. BMJ \n                           343, d5928 (2011).","journal-title":"BMJ"},{"key":"13745_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol \n                           25, 603\u2013605 (2010).","journal-title":"Eur J Epidemiol"},{"key":"13745_CR44","unstructured":"Review Manager (RevMan) Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration (2014)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13745-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13745-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13745-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:19:43Z","timestamp":1671797983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13745-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13745"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13745-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]},"assertion":[{"value":"27 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13451"}}